Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

ADIL holding history

Adial Pharmaceuticals, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADIL overviewAll 13F holders of ADILFull Q2 2026 holdings

Shares (Q2 2026)
50
Value
$128
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ADIL by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202650$128<0.1%00.0%UnchangedHolders
Q1 202650$90<0.1%+50+13,788.9%AddedConverted for a 1-for-25 splitHolders
Q4 20259$2<0.1%00.0%UnchangedHolders
Q3 20259$3<0.1%00.0%UnchangedHolders
Q2 20259$3<0.1%00.0%UnchangedHolders
Q1 20259$6<0.1%00.0%UnchangedHolders
Q4 20249$9<0.1%−300−97.1%ReducedHolders
Q3 2024309$309<0.1%+270+692.3%AddedHolders
Q2 202439$45<0.1%+24+160.0%AddedHolders
Q1 202415$20<0.1%+6+66.7%AddedHolders
Q4 20239$17<0.1%−12−57.1%ReducedHolders
Q3 202321$58<0.1%−0−1.9%ReducedConverted for a 1-for-25 splitHolders
Q2 2023535$111<0.1%00.0%UnchangedHolders
Q1 2023535$187<0.1%−42−7.3%ReducedHolders
Q4 2022577$124<0.1%−446−43.6%ReducedHolders
Q3 20221,023$00.0%+488+91.2%AddedHolders
Q2 2022535$1.00K<0.1%00.0%UnchangedHolders
Q1 2022535$1.00K<0.1%−3−0.6%ReducedHolders
Q4 2021538$1.00K<0.1%−39,690−98.7%ReducedHolders
Q3 202140,228$173.0K<0.1%+39,693+7,419.3%AddedHolders
Q2 2021535$1.00K<0.1%−4,665−89.7%ReducedHolders
Q1 20215,200$13.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.